Translation initiation in eukaryotes is a rate-limiting step in protein synthesis. It is a complicated process that involves many eukaryotic initiation factors (eIFs). Altering the expression level or the function of eIFs may influence the synthesis of some proteins and consequently cause abnormal cell growth and malignant transformation. P170, the largest putative subunit of eIF3, has been found elevated in human breast, cervical, esophageal, and lung cancers, suggesting that p170 may have a potential role in malignant transformation and/or cell growth control. Our recent studies suggested that p170 is likely a translational regulator and it may mediate the effect of mimosine on the translation of a subset mRNAs. Mimosine, a plant nonprotein amino acid, inhibits mammalian DNA synthesis, an essential event of cell growth. The rate-limiting step in DNA synthesis is the conversion of the ribonucleotides to their corresponding deoxyribonucleotides catalysed by ribonucleotide reductase of which the activity is regulated by the level of its M2 subunit. It has been reported that inhibiting the activity of M2 also inhibits cell growth. To understand the relationship between protein and DNA synthesis and between p170 and cell growth control, we investigated in this study whether p170 regulates the synthesis of M2 and, thus, cell growth. We found that altering the expression level of p170 changes the synthesis rate of both M2 and DNA. Decreasing p170 expression in human lung cancer cell line H1299 and breast cancer cell line MCF7 significantly reversed their malignant growth phenotype. However, the overall [ 35 S]methionine incorporation following dramatic decrease in p170 expression was only B25% less than the control cells. These observations, together with our previous findings, suggest that p170 may regulate the translation of a subset mRNAs and its elevated expression level may be important for cancer cell growth and for maintaining their malignant phenotype.
Translation initiation in eukaryotes is a rate-limiting step in protein synthesis. It is a complicated process that involves many eukaryotic initiation factors (eIFs). Altering the expression level or the function of eIFs may influence the synthesis of some proteins and consequently cause abnormal cell growth and malignant transformation. P170, the largest putative subunit of eIF3, has been found elevated in human breast, cervical, esophageal, and lung cancers, suggesting that p170 may have a potential role in malignant transformation and/or cell growth control. Our recent studies suggested that p170 is likely a translational regulator and it may mediate the effect of mimosine on the translation of a subset mRNAs. Mimosine, a plant nonprotein amino acid, inhibits mammalian DNA synthesis, an essential event of cell growth. The rate-limiting step in DNA synthesis is the conversion of the ribonucleotides to their corresponding deoxyribonucleotides catalysed by ribonucleotide reductase of which the activity is regulated by the level of its M2 subunit. It has been reported that inhibiting the activity of M2 also inhibits cell growth. To understand the relationship between protein and DNA synthesis and between p170 and cell growth control, we investigated in this study whether p170 regulates the synthesis of M2 and, thus, cell growth. We found that altering the expression level of p170 changes the synthesis rate of both M2 and DNA. Decreasing p170 expression in human lung cancer cell line H1299 and breast cancer cell line MCF7 significantly reversed their malignant growth phenotype. However, the overall [ 35 S]methionine incorporation following dramatic decrease in p170 expression was only B25% less than the control cells. These observations, together with our previous findings, suggest that p170 may regulate the translation of a subset mRNAs and its elevated expression level may be important for cancer cell growth and for maintaining their malignant phenotype.
Introduction
Translation initiation in eukaryotes is a complicated process that involves many eukaryotic translation initiation factors (eIFs). It is the rate limiting and the major regulation step of mRNA translation. In total, 11 or more translation initiation factors have been identified to involve in the translation initiation steps (Hershey and Merrick, 2000) . Any change in the level or function of the eIFs or their regulatory factors may influence the translation of some mRNAs and consequently the growth of cells. In fact, accumulating evidences suggest that deregulation of protein synthesis would decontrol the growth of cells and, thus, cancer. It has been reported that overexpression of eIF4E (Lazaris-Karatzas et al., 1990) , eIF4G (Fukuchi-Shimogori et al., 1997) , and the p48 subunit of eIF3 (Mayeur and Hershey, 2002) in NIH3T3 cells caused tumorigenic transformation. Abrogation of eIF2 phosphorylation was also shown to promote malignant cell transformation (Donze et al., 1995) . One possible explanation for the involvement of translation initiation factors in tumorigenesis is that the deregulated expression of translation initiation factors or their regulators may promote the translation of some protooncogenes or growth factors that normally are translationally repressed, such as c-myc, cyclin D1, and ornithine decarboxylase (De Benedetti and Harris, 1999; Hershey and Miyamoto, 2000) .
EIF3 is the most complex translation initiation factor with a molecular weight of about 550-700 kDa (Hershey and Merrick, 2000) . It is a complex consisting of 11 putative subunits and p170 is thought to be the major subunit when purified initially from rabbit reticulocyte lysate (Benne and Hershey, 1976) . However, the functional importance of p170 in translational control and in the eIF3 complex is not clear. The findings that p170 interacts with the other subunits of eIF3 (Methot et al., 1997; Block et al., 1998) , eIF4B (Methot et al., 1996) , and RNA (Block et al., 1998; Buratti et al., 1998) supports a role of p170 in eIF3 function and translation initiation.
Our previous study showed that p170 can mediate the effect of mimosine, a nonprotein plant amino acid, on the translation of a-tubulin and p27 transcripts in opposite directions (Dong and Zhang, 2003) . It has also been observed that eIF3 preparations relatively rich in p170 did not differ substantially in specific activity of stimulating formation of preinitiation complex from preparations that essentially lacked this protein (Chaudhuri et al., 1997) . Thus, it is possible that eIF3 p170 may regulate the translation of a subset of transcripts that are important for cell growth and proliferation. The eIF3 complexes with or without p170 may be responsible for the translation of different transcripts. It has been found recently that the p170 expression level is significantly elevated in human cancers of breast (Bachmann et al., 1997) , cervix (Dellas et al., 1998) , esophagus (Chen and Burger, 1999) , and lung (Pincheira et al., 2001) . The expression level of p170 was also found to oscillate with cell cycle and its expression level is repressed and elevated in G1 and S phases, respectively (Dong et al., manuscript in preparation) . These findings suggest that p170 may be involved in modulating cell proliferation and cell cycle progression.
The observation that p170 expression oscillates with cell cycle and peaks in S phase suggests that p170 expression may be important for regulating the expression of enzymes involved in DNA synthesis. Previously, it has been shown that the expression of ribonucleotide reductase M2, the enzyme that catalyses the ratelimiting step conversion of ribonucleotides to deoxyribonucleotides in DNA synthesis (Wright et al., 1990) , also oscillates during cell cycle and peaks in S phase (Engstrom et al., 1985; Bjorklund et al., 1990 Bjorklund et al., , 1992 and that its expression is controlled at the translational level (Eriksson et al., 1984) . The expression level and activity of M2 are critical to keep the balance of the dNTP pool and consequently influence the DNA synthesis (Gilbert et al., 1995) . Its expression is markedly altered in malignant cells exposed to tumor promoters (phorbol ester TPA) (Amara et al., 1994) or the transforming growth factor b (TGF-b) (Hurta and Wright, 1995) . Overexpression of M2 increased the malignant level of H-ras transformed fibroblast cells and enhanced the invasive potential of human cancer cells (Fan et al., 1996; Zhou et al., 1998) . Downregulating the expression level of M2 by antisense cDNA or oligonucleotides reduced the malignant level of human cancer cells in vitro (Chen et al., 2000) and in vivo (Lee et al., 2003) and also inhibited the metastasis of human melanoma cells (Lee et al., 2003) . These findings suggest that the ribonucleotide reductase M2 may be critically involved in mechanisms controlling malignant progression and that p170 may regulate M2 expression and, thus, cell growth and proliferation. Mimosine has been reported to inhibit DNA synthesis by inhibiting the synthesis of proteins that are important for the initiation and elongation of DNA synthesis and reducing the pool of dNTP (Gilbert et al., 1995; Kalejta and Hamlin, 1997) . In a previous study, we found that p170 is likely a mediator of mimosine effect on protein synthesis (Dong and Zhang, 2003) . Thus, it is possible that mimosine may affect the expression of M2 mediated by p170.
In this study, we investigated the possibility that p170 regulates the synthesis of M2 and that decreasing p170 expression by antisense would decrease M2 expression and, thus, change the malignant growth phenotype of cancer cells. We found that the M2 protein synthesis correlates with the p170 level and that downregulating the expression of p170 in cancer cell lines H1299 and MCF7 decreased the synthesis of both M2 and DNA. It also reversed the malignant growth phenotype of these cells. Thus, p170 expression is important for cancer cell growth and that overexpression of p170 is required for maintaining the malignant growth phenotype of H1299 and MCF7 cells possibly through regulating the translation of transcripts important for cell growth such as ribonucleotide reductase M2.
Results

Mimosine treatment decreases expression of ribonucleotide reductase M2
Previously, it has been reported that mimosine treatment downregulated the expression level of eIF3 p170 (Dong and Zhang, 2003) and reduced the deoxyribonucleotide pool (Kalejta and Hamlin, 1997) . We also found that p170 mediated the effect of mimosine on the translation of a subset mRNAs such as a-tubulin and p27. To investigate whether M2 mediates mimosine effect on the reduction of deoxyribonucleotide pool and whether p170 is involved in regulating the synthesis of ribonucleotide reductase M2, we first tested whether mimosine treatment affects the expression of ribonucleotide reductase M2. For this purpose, we treated HeLa cells with mimosine and determined M2 protein level by Western blot analysis. As shown in Figure 1a and c, the level of M2 protein began to decrease around 4 h following mimosine treatment, suggesting that the effect of mimosine on reduced deoxyribonucleotide pool is likely due to its effect on the level of M2. Note that the cell cycle distribution was not changed following 8 h of mimosine treatment (Dong and Zhang, 2003) . The observation that M2 decreased around 4 h following mimosine treatment is similar to the previous findings that the levels of both a-tubulin and p27 also began to change around 4 h. However, the level of eIF3 p170 began to decrease around 2 h following mimosine treatment (see Figure 1a and also Dong and Zhang, 2003) . Therefore, the change in p170 expression level precedes the change in M2 level following mimosine treatment and it is possible that p170 also mediates mimosine effect on the expression of M2, similar to that of a-tubulin and p27.
To determine at which level mimosine treatment decreases M2 expression, we first performed a Northern blot analysis of M2 mRNA at different time points following mimosine treatment. As shown in Figure 1b and 1c, within the 8-h period of mimosine treatment, the steady-state level of M2 mRNAs did not decrease. It is noteworthy that two major M2 transcripts of different lengths were detected as shown in previous studies (Park and Levine, 2000; Zhou and Yen, 2001 ). This observation suggests that the mimosine effect on the decrease in M2 expression is not at the mRNA level (e.g., transcription or degradation of mRNA).
To determine whether the synthesis of M2 protein is altered by mimosine, we performed a pulse labeling study with [ 35 S]methionine followed by immunoprecipitation of M2. As shown in Figure 1d , the M2 protein synthesis following 8-h mimosine treatment was decreased to less than one-third of the untreated cells. To further determine whether mimosine treatment affects the stability of M2 protein, we performed a pulse-chase and immunoprecipitation experiment. As shown in Figure 1e , the degradation rate of M2 protein was the same between cells chased in the absence or presence of mimosine with a half-life around 3 h. Together, these results suggest that mimosine treatment decreases M2 level by inhibiting the synthesis of M2 protein.
P170 mediates mimosine effect on M2 expression
Previously, we found that eIF3 p170 mediated mimosine effect on the synthesis of a-tubulin and p27. As mimosine effect on M2 is delayed after p170, similar to p27 and a-tubulin (see above and Dong and Zhang, 2003) , it is possible that p170 also mediates mimosine effect on M2 translation. To test this possibility, we took advantage that the p170 expression level could be altered by transient transfection of antisense or sense p170 cDNA in HeLa and NIH3T3 cells as shown previously (Dong and Zhang, 2003) and determined whether M2 level would change accordingly. HeLa and NIH3T3 cells were used because the former express high levels of p170 whereas the latter express low levels of p170. As shown in Figure 2a (Figure 2a) , whereas upregulating p170 expression in NIH3T3 cells also increased the level of M2 (Figure 2b) . However, the and mRNA (') as determined by gel densitometer from (a) and (b), respectively, and by normalization to the internal control actin or GAPDH. The de novo synthesis and degradation of M2 protein were analysed by pulse labeling (d) and pulse-chase labeling (e), respectively, in the absence (') or presence (m) of 600 mM mimosine Regulation of DNA synthesis and cell growth by eIF3 p170 Z Dong et al mRNA level of M2 was not altered by transient transfection of p170 cDNAs (data not shown). Furthermore, using the pulse-labeling study we found that the de novo synthesis of M2 protein decreased in HeLa cells by downregulating the expression level of p170 ( Figure 2c ). On the other hand, upregulating p170 in NIH3T3 cells also increased the de novo synthesis of M2 protein ( Figure 2d ). Thus, likely p170 regulates the synthesis of M2 protein.
Mechanism of p170 regulation of M2 expression
To investigate how the translation of M2 was regulated by p170, we first tested whether down-and up-regulated the p170 level affect the level of eIF3 containing p170 by determining the level of other eIF3 subunits. As shown in Figure 2e and f, down-or up-regulated the expression of p170 did not change the expression level of other subunits of eIF3, such as p116, p44 and p66, and that of eIF2a and eIF2b. Thus, it is possible that the eIF3 complex following the changes in p170 level has two forms with and without p170 subunits. To test this possibility, we decreased the expression of p170 in H1299 cells with antisense p170 cDNA ( Figure 3a ) and immunoprecipitated eIF3 complex using antibody against eIF3 p66 followed by Western blot to determine the level of p170 and p116 (eIF3Z) subunits in the precipitate. We found that indeed p170 was less in the eIF3 complex in the cells transfected by antisense p170 than that in the vector control cells, while the amount of p116 was similar in both vector and antisense p170 transfected cells ( Figure 3b ). Thus, it is likely that two populations of eIF3 complex (with and without p170 subunit) exist in cells treated with antisense p170 cDNA, which may have different functions in performing translation initiation of mRNAs and that, thus, p170 may be a regulator of eIF3 function.
To further determine how p170 regulates the synthesis of M2 protein, we engineered a reporter construct (pCR-SVL-M2) in which the luciferase reporter gene was cloned between the 5 0 -and 3 0 -UTR sequences of M2 ( Figure 4a ). Previously, we have shown that p170 also regulates the translation of p27 but in an opposite direction from its effect on M2. We, thus, also engineered a similar reporter construct (pLSVL-p27) for p27 ( Figure 4a ). We next analysed the effect of the altered p170 expression level on the synthesis of the reporter protein by cointroducing the two reporterconstructs with antisense and sense p170 cDNAs into H1299 and NIH3T3 cells, respectively. As shown in Figure 4b and c, the production of the reporter luciferase in the presence of the 5 0 -and 3 0 -UTRs of M2 was decreased in H1299 cells by transfection of antisense p170 cDNA ( Figure 4b ) and increased in NIH3T3 cells by transfection of sense p170 cDNA ( Figure 4c ). On the other hand, the production of the reporter luciferase in the presence of the 5 0 -and 3 0 -UTRs of p27 was increased in H1299 cells by transfection of antisense p170 cDNA and decreased in NIH3T3 cells by transfection of sense p170 cDNA. However, RNase protection assay showed that the luciferase RNA levels of these transfected cells were not changed by decreasing the p170 level using antisense (Figure 4d) or increasing the p170 level using sense cDNA ( Figure 4e ). Thus, the differences of the luciferase activity observed in Figure  4b and c were likely due to the difference in the translation of the reporter transcripts in these cells. As Figure 3 The level of p170 in the immunoprecipitated eIF3 complex. H1299 cells transfected with antisense p170 cDNA and vector were lysed and used for immunoprecipitation of eIF3 complex using anti-p66 antibody as described in Materials and methods. The level of p170 and p116 (eIF3Z) subunits in the eIF3 complex was determined using Western blot of the precipitate (b). Decreased expression of p170 by antisense cDNA was confirmed by Western blot of total cell lysate (a) and sense (Sens) p170 cDNA, respectively. The effect of the change in p170 expression on the expression level (a and b) and synthesis (c and d) of M2 was determined using Western blot and pulse labeling, respectively, as described in Materials and methods. The effect of the change in p170 expression on the expression level of other subunits of eIF3 and eIF2 were also determined by Western blot (e and f). Vector-transfected cells (Vec) were used as controls for transfection. Actin was used as a loading control for Western blot Regulation of DNA synthesis and cell growth by eIF3 p170 Z Dong et al the two reporter constructs are similar with only differences in the 5 0 -and 3 0 -UTRs and the effect of p170 on them is completely different, we conclude that p170 likely regulates the translation of M2 and p27 mRNAs. However, it should be noted that the above studies do not rule out the possibility that the effect of p170 on M2 translation may be indirect through other yet unknown factors.
Antisense p170 cDNA suppresses endogenous p170 expression in stably transfected cancer cell lines
To further examine the regulation of M2 expression and to determine whether p170 is an upstream regulator of M2 expression in cell growth control, stable clones expressing antisense p170 were established using the H1299 cell line. As shown in Figure 5 , H1299 cell clones that express lowered levels of endogenous p170 in comparison with the untransfected and vector-transfected control cells were screened using Western blot. It appears that the antisense clones have substantially decreased expressions of p170 albeit with different levels of downregulation (Figure 5b) . For further studies, we chose two antisense clones from the transfected cell lines (clones 4 and 5), which were named as H1299-AS4 and H1299-AS5.
To determine the expression level of M2 in H1299-AS4 and H1299-AS5 cells, we performed Western blot analysis. As shown in Figure 6a Effect of p170 level on luciferase expression in H1299 cells. H1299 cells were cotransfected by pCR-SVL-M2 or pLSVLp27 reporter construct together with antisense p170 cDNA and b-gal followed by lysate preparation and luciferase activity assay as described in Material and methods. (c) Effect of p170 level on luciferase expression in NIH3T3 cells. NIH3T3 cells were cotransfected by pCR-SVL-M2 or with pLSVLp27 reporter construct together with sense p170 cDNA and b-gal followed by lysate preparation and luciferase activity assay as described in Material and methods. Vectors (Vec) that do not harbor the p170 cDNA were used as controls for transfection. The luciferase activity was normalized by b-gal activity and then to the vector control. (d and e) RNase protection assay of luciferase mRNA. The mRNA levels of the luciferase reporter gene in the transfected H1299 (c) and NIH3T3 (d) cells as described in (b) and (c) were determined by using RNase protection assay as described in the Materials and methods. The constitutively expressed gene, GAPDH, was used as a control Regulation of DNA synthesis and cell growth by eIF3 p170 Z Dong et al the [ 3 H]thymidine incorporation level was decreased with the decreased M2 level in H1299-AS4 and H1299-AS5 cells. Thus, it is likely that decreasing p170 level by antisense p170 decreased M2 level, which in turn decreased DNA synthesis. However, it is noteworthy that only B50% decrease in DNA synthesis was observed with the drastic decreases in M2 level by antisense p170. This less drastic decrease in DNA synthesis may be due to the compensation of M2 losses by other M2 isozymes, such as p53R2 (Tanaka et al., 2000) .
Suppression of p170 expression can reverse the malignant phenotype of cancer cells
It has been shown previously that the deregulated expression of M2 is a critical component in controlling malignant progression and enhances the invasive potential of cancer cells (Fan et al., 1996; Zhou et al., 1998; Chen et al., 2000; Lee et al., 2003) . It is possible that the altered expression of p170 may change the expression level of proteins important for growth control such as M2 and, thus, malignant phenotype. To test this hypothesis, we examined the growth properties of the antisense clones of H1299 lung cancer cells and found that the growth property of the antisense clones was remarkably different from that of vector-transfected control cells. The efficiency of colony formation by the antisense clones was as low as 20% (32% on average) of vector-transfected control cells (compare vector control and antisense clones in Figure 7a and d) . The colonies formed by the antisense clones also appeared to be smaller than the vector-transfected control cells. Moreover, the antisense clones lost their ability to grow in soft agar (Figure 7b and e). The antisense clones could form as less as 7% (14% on average) colonies of the vector-transfected control cells growing under the same condition in soft agar. The antisense clones also grew much slower than vector-transfected cells (Figure 7c ). The estimated doubling time of antisense clones is 52-59 h. However, the doubling time of vector-transfected control cells is B32 h. These results suggest that suppressing the overexpression of p170 can substantially change the malignant growth phenotype of H1299 lung cancer cell line.
Effect of suppression of p170 expression on global protein synthesis
Since p170 is a putative subunit of eIF3, it is possible that the drastic decrease in p170 level by antisense technology dramatically decreased the global protein Suppression of p170 expression can also change the growth phenotype of breast cancer cells
In the above studies, we found that p170 is a regulator of the M2 expression and that downregulation of p170 level can change the growth phenotype of lung cancer cell line H1299. These observations suggest that p170 expression is important for cell growth control and for maintaining the malignant phenotype of lung cancer cells. Overexpression of p170 has also been observed with human breast cancers (Bachmann et al., 1997) . To further demonstrate that p170 overexpression is important for malignant phenotype, we tested the effect of decreasing p170 level on malignant phenotype of MCF7 cells using the same strategy as described above. As shown in Figure 8a , the antisense clones of MCF7 cells expressed lowered levels of endogenous p170 in comparison with the untransfected and vector-transfected clones. The two clones chosen for further study were named as MCF-AS5 and MCF7-AS8.
The growth property of the antisense clones is also remarkably different from that of vector-transfected control cells, similar to the findings of H1299 cells. The efficiency of colony formation by the antisense clones was as low as 22% (36% on average) of vectortransfected control cells (compare vector control and antisense clones in Figure 8b ). The colonies formed by the antisense clones also appeared to be smaller than the vector-transfected control cells. The antisense clones also lost their ability to grow in soft agar (Figure 8c ). The antisense clones could form as less as 14% (15% on average) colonies of the vector-transfected control cells growing under the same condition in soft agar. The antisense clones also grew much slower than vectortransfected cells (Figure 8d ) although still maintaining B75% of the total [ 35 S]methionine incorporation (Figure 8e ). These observations are similar to that found with the H1299 cells discussed above. Thus, the downregulation of p170 overexpression can also drastically change the malignant phenotype of MCF7 cells.
Discussion
DNA synthesis is an essential event of cell growth and, thus, the regulation of DNA synthesis is an important mechanism to control cell proliferation. It has been reported that one of the rate-limiting steps of DNA synthesis is the conversion of the ribonucleotides to their corresponding deoxyribonucleotides (Wright et al., 1990) . This reaction is catalysed by ribonucleotide reductase consisting of two different components, M1 and M2. The expression of the M1 subunit appears to be constant throughout the cell cycle (Engstrom et al., 1985; Mann et al., 1988) whereas that of M2 oscillates with cell cycle and increases in the S phase by increased de novo synthesis (Eriksson et al., 1984; Bjorklund et al., 1990) . Downregulating the expression level of M2 by antisense technology can cause the decrease of ribonucleotide reductase activity and the colony formation ability of cells (Chen et al., 2000) . Antisense oligonucleotides targeting the human ribonucleotide reductase M2 subunit can inhibit the growth of human tumor and metastasis of human melanoma cells in vivo (Lee et al., 2003) . However, downregulating M1 level revealed no significant inhibition (Chen et al., 2000) . It has also been shown that the activity of ribonucleotide reductase, and therefore DNA synthesis and cell proliferation, is controlled during cell cycle by the synthesis and degradation of the M2 subunit (Eriksson et al., 1984) . Several antiproliferation agents such as hydroquinone, orotic acid, and hydroxyurea were reported to inhibit DNA synthesis by inhibiting the expression or activity of M2 and consequently reducing the deoxyribonucleotide pool (Yarbro, 1992; Zhou et al., 1995; Li et al., 1998; Manjeshwar et al., 1999) .
Another well-known DNA synthesis inhibitor, mimosine, has also been reported to inhibit DNA synthesis by reducing the deoxyribonucleotide pool (Kalejta and Hamlin, 1997). However, the mechanism of mimosine effect on reduced production of deoxyribonucleotides is not known. In this study, we found that the level of M2 in HeLa cells decreased at 4 h following mimosine treatment. This decrease was not associated with the change of mRNA level and the protein degradation rate, but with the decrease in the de novo synthesis of M2 protein. Therefore, mimosine downregulates the expression level of M2 at the translational level, which in turn reduces the production of deoxyribonucleotides. We also found that overexpression of p170 in NIH3T3 cells by transient transfection can increase the synthesis rate and the expression level of M2. Downregulating the p170 level in HeLa cells by transient transfection of antisense p170 cDNA decreased the expression and synthesis rate of M2. However, the level of other subunits of eIF3 and eIF2 remained the same following alteration of the expression level of p170. Thus, it is likely that p170 regulates M2 synthesis and mediates the mimosine effect on M2 synthesis. This observation supports our previous conclusion that p170 mediates the mimosine effect on the translation of a subset mRNAs. It is also consistent with previous findings that cells treated with mimosine lack proteins required for DNA replication with a reduced deoxyribonucleotide pool (Gilbert et al., 1995; Kalejta and Hamlin, 1997) . It has been reported that a group of mRNAs was found to relocate into mono-ribosome pool from poly-ribosome fraction following mimosine treatment and they reappeared in poly-ribosome pool when mimosine was removed (Hanauske-Abel et al., 1995) . Thus, mimosine may modulate the synthesis of some proteins that associate with the initiation and elongation of DNA replication as well as the synthesis of deoxyribonucleotides.
Previous work has shown that the expression of ribonucleotide reductase, and in particular the M2 subunit, is markedly altered in malignant cells exposed to tumor promoter 2-O-tetradecanoylphorbol-13-acetate (TPA) (Amara et al., 1994) or TGF-b (Hurta and Wright, 1995) . Overexpression of M2 increased the malignant level of H-ras transformed fibroblast cells and enhanced the invasive potential of human cancer cells (Fan et al., 1996; Zhou et al., 1998) . Downregulating the expression of M2 by antisense cDNA or oligonucleotides reduced the malignant level of human cancer cells in vitro (Chen et al., 2000) and in vivo (Lee et al., 2003) and also inhibited the metastasis of human melanoma cells (Lee et al., 2003) . These findings suggest that the M2 subunit of ribonucleotide reductase may be a malignancy determinant and critically involve in mechanisms controlling malignant progression. The finding that p170 can positively regulate the expression of M2 suggests that the high expression level of p170 is essential for the malignant growth of the cancer cells in which the p170 expression level is elevated. Indeed, we found that the malignant growth phenotype of cancer cell lines H1299 and MCF7 were changed drastically by downregulating p170 expression using antisense technology. Thus, p170 expression is important for cancer cell growth and overexpression of p170 is required for maintaining the malignant phenotype. However, it is noteworthy that p170, as discussed below, may regulate the translation of a subset mRNAs of which some in addition to M2 may be the mediator for p170 regulation in cell growth and malignancy.
The diminished expression of endogenous p170 in antisense clones (Figures 5 and 8a) is accompanied by an only B25% global decrease in protein synthesis ( Figure  7f and 8e) . In contrast, the decreased expression of eIF4E by antisense approach decreased global protein synthesis by 90% in HeLa cells (De Benedetti et al., 1991) . Thus, it is possible that, unlike eIF4E, eIF3 p170 may not be essential for global protein synthesis. It may function as a regulator for translation of a subset mRNAs. Consistent with this hypothesis, we found that the eIF3 complex likely exists in two forms with and without the p170 subunits following antisense p170 cDNA transfection (Figure 3) . It is possible that the eIF3 complex with and without p170 is required for translation of different mRNAs. Interestingly, Chaudhuri et al. (1997) has shown previously that the presence of p170 was not necessary for the function of eIF3 in stimulating the in vitro formation of the 40S preinitiation complex.
It has been suggested that eIF5A, another translation initiation factor, also functions as a regulator for translation and it may regulate translation of a subset cellular mRNAs. The expression of functional eIF5A is also inhibited by mimosine treatment which generates an unmodified eIF5A lacking hypusine residue (Hanauske-Abel et al., 1994; Andrus et al., 1998) . We found that mimosine treatment inhibits B50% of global protein synthesis (Dong and Zhang, 2003) while severe depletion of eIF5A resulted in an B30% decrease in the global protein synthesis (Kang and Hershey, 1994) . In the light of our current finding that severe depletion of p170 resulted in an B25% decrease in global protein synthesis, it is tempting to propose that the mimosine effect on global protein synthesis is mediated by both eIF5A and p170. The 25% global decrease in protein synthesis due to severe depletion of p170 is likely generated by the severe decrease in translation of a subset of mRNAs but not due to global decrease in translation of all mRNAs.
Previously, De Benedetti et al. (1991) showed that decreasing global protein synthesis by 90% in HeLa cells did not alter the morphology and malignant phenotype of these cells. We also found that treatment with cycloheximide to inhibit total protein synthesis did not alter the morphology of HeLa cells (Dong and Zhang, unpublished observation) . Thus, we believe that a global decrease of 25% in protein synthesis alone is unlikely responsible for the loss of malignant phenotype of H1299 and MCF7 cells. It is noteworthy that the severe depletion of p170 does not only decrease the translation of some mRNAs such as M2, it also increases the translation of other mRNAs such as p27 (Dong and Zhang, 2003) . Thus, it is very likely that the severe change in translation of the subset mRNAs such as M2 and p27 due to depletion of p170 is responsible for the change of malignant phenotype of H1299 and MCF7 cells. It is possible that the elevated expression of p170 in cancer cells upregulates M2 expression and downregulates p27 expression, which in turn helps cells go through the cell cycle and increases DNA synthesis for cell growth. Decreasing the level of p170 by antisense manipulation will decrease the DNA synthesis and cell growth rate and, thus, reverse the malignant phenotype. This is consistent with a previous finding that overexpression of eIF4E in fibroblast cells led to malignant transformation and it was thought that eIF4E might be regulating synthesis of proteins important for cell growth control (Lazaris-Karatzas et al., 1990) , such as ribonucleotide reductase M2 (Abid et al., 1999) .
Currently, it is unknown how p170 regulates the translation of the subset mRNAs including ribonucleotide reductase M2. It is possible that p170 can bind to the 5 0 -and/or 3 0 -UTR of mRNAs and the different UTR sequences have different responses to p170 level as we found with that of M2 and p27. Although p170 does not have an obvious RNA-binding motif, it has been shown that p170 bind to mRNAs (Block et al., 1998; Buratti et al., 1998) . P170 may also regulate translation by binding to eIF3 and changing its conformation so that the eIF3 complex cannot bind to some mRNAs while it binds better to other mRNAs for less and better translation efficiency, respectively. Alternatively, p170 may regulate the translation of M2 indirectly by regulating the synthesis of the protein factors that control the translation of M2. It has been reported that M2 has two major transcripts with different 5 0 -UTRs. One has a shorter 5 0 -UTR with 63 nucleotides while the other has a longer 5 0 -UTR with 222 nucleotides (Park and Levine, 2000; Zhou and Yen, 2001 ). The long 5 0 -UTR, which was used in this study, possesses four inframe AUG codons which may act as translation regulation element (Fernandez et al., 2002) . Currently, it is unknown whether both mRNA species are regulated. However, it is tempting to propose that the translation of the two transcripts is regulated by different factors and through different mechanisms. We are currently addressing these questions and investigating the role of p170 in regulating the translation of the two M2 mRNAs.
Antisense approach has been used in various studies to decrease the expression of target genes. Although the mechanism of antisense effect is not well understood, it has been thought that the antisense strand hybridizes to either genomic DNA to inhibit transcription or to mRNA to inhibit translation of the target gene. In this study, we found that the p170 mRNA still exists in the antisense clones by RT-PCR (unpublished observation), suggesting that the antisense p170 likely inhibits mRNA translation. However, the antisense approach has a potential problem that it may cause nonspecific effect on the expression of other genes. For example, antisense p170 may hybridize to other mRNAs in addition to p170 mRNA and, thus, inhibit translation of these mRNAs. The inhibition of translation of these mRNAs may in turn affect the cell growth phenotype. This possibility cannot be ruled out in the current study. However, examination of p170 and M2 sequence did not show any significant homology, and the mRNA level of M2 did not change following transfection of antisense p170 (unpublished observation). Furthermore, in a previous study, we found that the translation of p27 was increased following transfection of antisense p170. Thus, the decreased expression of M2 and the change in malignant growth phenotype of the cancer cells following antisense p170 treatment is unlikely due to the nonspecific effect. 
Materials and methods
Materials
Construct engineering
The sense and antisense p170 expression constructs in pTracer Á CMV2 and pCbA vectors were engineered as previously described (Dong and Zhang, 2003) . The reporter expression constructs were generated by first subcloning the luciferase gene from pGL3 (Promega) directly into the EcoRI and BamHI sites of pCRII (Invitrogen) to create pCRL. The simian virus 40 (SV40) promoter was inserted in front of the luciferase gene into the EcoRI and XhoI sites of pCRL to create plasmid pCR-SVL. The 5 0 -and 3 0 -UTR sequences of the human M2 gene were cloned by PCR using genomic DNA and mRNA as templates, respectively, with the following primers:
0 . The 5 0 -and 3 0 -UTR PCR products were then cloned simultaneously into the NcoIEcoRI sites and XbaI-BamHI sites of pCR-SVL, respectively, resulting in the construct pCR-SVL-M2. The 5 0 -UTR sequence of p27 was amplified from genomic DNA using primers as follows: P27-5 0 -PF: 5 0 -CGGAATTCGTCA GCCTCCC TTCCACC-3 0 ; P27-5 0 -PR: 5 0 -CGGGGATCCCTTTCTCCC GGGTCTGCA-3 0 . The PCR product was then cloned into EcoRI-BamHI sites of pSVL plasmid that contains luciferase gene and the 3 0 -UTR of p27, resulting in the construct pLSVL-p27.
The 352-base fragment in the coding region of the luciferase gene was released from pCR-SVL by digestion with HincII and XbaI and was cloned into EcoRV-XbaI sites of the pCR II vector (Invitrogen), resulting in construct pCRLP that was used to produce RNA probe by in vitro transcription to detect the luciferase mRNA using RNase protection assay.
Cell lines, treatment, and transfection
Human large cell lung cancer cell line H1299 and breast cancer cell line MCF7 were maintained in RPMI1640 and IMEM supplemented with 10% fetal bovine serum in a humidified incubator at 371C with 5% CO 2 . Maintenance of HeLa and NIH3T3 cells, mimosine treatment, and transient transfection were performed exactly as previously described (Dong and Zhang, 2003) .
For stable transfection, semiconfluent H1299 and MCF7 cells were transfected with 4 mg pTracer Á CMV2-P170AS or pTracer Á CMV2 vector using Lipofectamine/Plus (Invitrogen). Zeocint (Invitrogen) was added to a concentration of 100 mg/ ml at 48-72 h post-transfection to select stable clones. The medium was changed every 2-3 days until the isolated cell clones were observed. Single colonies were then picked and transferred to a 96-well plate for expansion and further analysis.
Sample preparation, Western blot, and immunoprecipitation
Cell lysate preparation, Western blot, and immunoprecipitation of M2 were performed exactly as previously described (Dong and Zhang, 2003) . The antibodies used for Western blots were p170 polyclonal antibody AbD (1 : 1000 dilution), actin monoclonal antibody (1 : 3000 dilution), M2 monoclonal antibody YL1/2 (1 : 500 dilution), p116 (hPrt1) polyclonal antibody (1 : 1000 dilution), and other antibodies against the subunits of eIF3 and eIF2a and eIF2b (diluted according to the manufacture's guidelines).
Immunoprecipitation of the eIF3 complex was performed as follows. Cell lysates were prepared by lysis of cells with TNNTriton buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 50 mM NaF, 1 mM sodium orthovanadate, 1 mM dithiothreitol, 1% Triton X-100, and 2 mM phenylmethylsulfonyl fluoride). Cell lysates of 300-500 mg proteins were diluted with lysis buffer to 600 ml and with 10% BSA to a final concentration of 2%. The eIF3 complex was then precipitated by adding antibody against eIF3 p66 using the protocol previously described (Dong and Zhang, 2003 ). The final precipitate was then separated by SDS-PAGE for Western blot analysis using p170 monoclonal antibody M116 (1 : 25 dilution) and p116 (eIF3Z) polyclonal antibody (1 : 100 dilution).
Luciferase reporter assay
For the effect of decreased p170 expression, 1.4 Â 10 5 H1299 cells per well in a 12-well-plate were transfected with 2.55 mg pTracer Á CMV2-P170AS or 1.5 mg pTracer Á CMV2 vector control together with 100 ng of pCMV-b-gal and 0.4 mg of reporter plasmids (pCR-SVL-M2 or pLSVL-p27). For the effect of p170 overexpression, 9 Â 10 4 NIH3T3 cells per well in a 12-well-plate were transfected with 1.8 mg pCbA-p170 or 1 mg pCbA vector control together with 100 ng of pCMV-b-gal and 0.5 mg reporter plasmids (pCR-SVL-M2 or pLSVL-p27). The cells were harvested at 48 h following transfection for lysate preparation and luciferase activity assay using the luciferase assay system (Promega) as previously described (Han and Zhang, 2002) . The activity of b-gal was measured as described previously (Sambrook et al., 1989) .
RT-PCR
Total RNA was isolated from H1299, MCF7, and their derivative antisense-expressing clones using a kit from Qiagen. RT-PCR was performed using standard protocols with AMV reverse transcriptase (Invitrogen), and the following primers for reverse transcription: 5 0 -CCACTAGAGAGTTCGCTGA-3 0 (PAS1) for antisense p170 RNA and 5 0 -CGTCTGGGGG ATGATGAA-3 0 (P7) for sense p170 RNA and the following primers for PCR reaction: 5 0 -GATCCGGCCTATTTTCA-GAGGCCGGA-3 0 (PAS2) and 5 0 -GGCAATATCATGGTA-CAG GCGCTCTA-3 0 (PAS3) for antisense p170 RNA and 5 0 -CGTCTGGGGGATGATGAA-3 0 (P7) and 5 0 -GAAAGGCA-TAATCGATTGGAA-3 0 (P8) for sense p170 RNA.
Metabolic labeling
In all, 1 Â 10 5 cells per well were plated in a 24-well plate in triplicates and the cells were then incubated for 24 h followed by washing three times with serum-free and methionine-free medium. The cells were pulse-labeled for 30 min with 20 mCi/ ml [ 35 S]methionine (41000 Ci/mmol; DuPont/NEN), washed for three times, and trypsinized. The cells were counted and precipitated with 10% TCA. The acid-insoluble material was collected on a filter by rapid filtration and the radioactivity was determined by scintillation counting.
For thymidine incorporation assay, 1 Â 10 5 cells per well were seeded in a 24-well plate in triplicates and the cells were then incubated for 24 h followed by washing three times with serum-free medium. The cells were pulse-labeled for 1 h with 3 mCi/ml [ 3 H]thymidine (60 Ci/mmol; ICN), washed for three times with PBS, and trypsinized. The cells were counted and precipitated with 10% TCA. The acid-insoluble material was collected on a filter by rapid filtration and the radioactivity was determined by scintillation counting.
Pulse and pulse-chase labeling of cells
Cells were washed twice with PBS and once with DMEM medium lacking methionine followed by incubation for 2 h in the same medium supplemented with 75 mCi/ml [ 35 S]methionine. The pulse-labeled cells were then washed three times with PBS and harvested for cell lysate preparation and immunoprecipitation. To chase the labeling, the cells were washed twice with PBS and once with DMEM medium following the 2 h pulse-labeling. The cells were then cultured in DMEM medium supplemented with 100 mg/ml cold methionine in the absence or presence of 600 mM mimosine up to 8 h. After washing three times with PBS, the cells were harvested for cell lysate preparation and immunoprecipitation.
RNA extraction, Northern blot, and RNase protection assay
The cells were harvested and the total RNA was extracted using RNeasy Mini Kit (Qiagen). About 20-30 mg total RNAs were separated by electrophoresis in 1.2% agarose-formaldehyde gels, transferred onto nitrocellulose membranes, and probed with cDNAs labeled with 32 P using RediprimetII Random Prime labeling system (Amersham Biosciences). The hybridization and washing conditions were as described previously (Dong et al., 1998) . The blots were stripped and reprobed with the probe of constitutively expressed human GAPDH gene as a control.
RNase protection assay of the luciferase mRNA was performed as previously described (Dong and Zhang, 2003) . Briefly, the construct pCRLP was linearized by digestion with BamHI and used as a template for in vitro transcription to make RNA probes using a kit from Ambion. RNase protection assay was performed with 20 mg total RNAs using the RPA-III kit (Ambion). The constitutively expressed human GAPDH gene was used as a control.
Determination of cell growth phenotype
To determine the cell growth rate, equal number of cells (500 per well) was plated in 96-well plates and maintained for various periods of time up to 14 days. Every 2-3 days after plating, medium was changed and one plate was used to determine cell density. Briefly, medium was removed and cells were washed and stained with crystal violet (0.5% crystal violet in 20% methanol) for 10 min. The plate was then washed thoroughly with tap water, air-dried, and extracted with 200 ml Sorenson's citrate buffer (0.1 M sodium citrate, pH 4.2 in 50% ethanol) for 1 h with shaking. The OD 595 nm of each extract was determined using a microplate reader and the cell numbers of each sample were calculated from a standard curve.
Cloning efficiency assay was performed by seeding 100 cells per well in six-well plates and by maintaining the cells for 10-14 days at 371C with medium changed every 2-3 days. At the end of assay, cell colonies were stained with crystal violet (0.5% crystal violet in 20% methanol) for 20 min and washed thoroughly with water. The visible colonies were counted manually.
Cell growth in soft agar was performed as previously described (Jiang et al., 1993) . Briefly, cells were suspended at a density of 2.5 Â 10 3 cells/ml in 0.3% agar solution in medium containing 10% fetal bovine serum. In all, 1 ml of this suspension was overlaid on top of a 0.6% agar layer made in medium with 10% fetal bovine serum in a six-well plate. Cells were then fed every 3-5 days for 14-25 days with fresh medium supplemented with 10% fetal bovine serum. At the end of each assay, visible colonies were counted manually.
